Overexpression of p16INK4A in liquid‐based specimens (SurePath™) as marker of cervical dysplasia and neoplasia
- 25 November 2002
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 27 (6) , 365-370
- https://doi.org/10.1002/dc.10205
Abstract
Human papillomavirus (HPV) is recognized as a causal agent for cervical carcinomas. Assimilation of HPV oncogenes E6 and E7 into the host DNA promotes upregulation of cyclin dependent kinase inhibitor (CDKI) p16INK4A, detectable by monoclonal antibody in the developing cervical cancer cells. The aim of this study was to 1) develop a protocol for p16INK4A immunocytochemical staining on SurePath™ preparations, and 2) determine its utility as an HPV marker on a spectrum of cervical reactive and neoplastic lesions. Seventy‐two specimens consisting of 28 nonneoplastic/nondysplastic cases (NN), one reactive glandular cells (RGC), 27 low‐grade squamous intraepithelial lesions (LSIL), 10 high‐grade squamous intraepithelial lesions (HSIL), one squamous cell carcinoma (SCCA), four atypical glandular cells (AGUS), and two adenocarcinomas (ADCA) were reprepped by SurePath™ and antibody to p16INK4A applied at 1:100 dilution using the Dako Envision + System on the Dako Autostainer. Expression of p16INK4A within the nucleus principally and cytoplasm of at least 10–15 cells was considered positive. All initial Papanicolaou‐stained discrepant cases (p16INK4A positivity of NN and RGC cases and lack of reactivity in LSIL, HSIL, and AGUS) were reviewed. Nine of ten (90%) HSIL, one (100%) SCCA, 21/27 (78%) LSIL, and some reactive and inflammatory specimens demonstrated the presence of p16INK4A. Reevaluation of discrepant cases revealed that several were underinterpreted (four NN were LSIL, one RGC was AGUS) or overinterpreted (one LSIL was NN). Following reassessment, false‐positive staining was present in only 1/25 (1.4%) NN. Six of 30 (20%) LSIL lacked p16INK4A positivity. One of 10 (10%) HSIL had no staining. Two of four AGUS did not react with p16INK4A antibody. Both SCCA (1) and ADCA (2) had positive expression. This study confirms the intimate relationship between p16INK4A and HPV cytopathic effect. The p16INK4A immunocytochemical stain can be applied to liquid‐based cervical preparations. This technique offers a more objective approach to deciphering “gray areas” of gynecologic cytopathology. Diagn. Cytopathol. 2002;27:365–370.Keywords
This publication has 11 references indexed in Scilit:
- The 2001 Bethesda SystemTerminology for Reporting Results of Cervical CytologyJAMA, 2002
- Procedure for Immunocytochemical Detection of P16INK4A Antigen in Thin-Layer, Liquid-Based SpecimensActa Cytologica, 2002
- Ki-67, Cyclin E, and p16 INK4 Are Complimentary Surrogate Biomarkers for Human Papilloma Virus-Related Cervical NeoplasiaThe American Journal of Surgical Pathology, 2001
- Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteriInternational Journal of Cancer, 2001
- Interobserver Reproducibility of Cervical Cytologic and Histologic InterpretationsRealistic Estimates From the ASCUS-LSIL Triage StudyJAMA, 2001
- Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource SettingsJNCI Journal of the National Cancer Institute, 2000
- Expression Status of p16 Protein Is Associated with Human Papillomavirus Oncogenic Potential in Cervical and Genital LesionsThe American Journal of Pathology, 1998
- Absence ofp15INK4Bandp16INK4AGene Alterations in Primary Cervical Carcinoma Tissues and Cell Lines with Human Papillomavirus InfectionGynecologic Oncology, 1998
- Inter‐ and intra‐observer variation in the histopathological reporting of cervical squamous in traepithelial lesion susing a modified Bethesda grading systemBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998